Increased Free Water in the Substantia Nigra in Asymptomatic LRRK2 G2019S Mutation Carriers

被引:4
|
作者
Zhang, Dongling [1 ,2 ,3 ]
Zhou, Liche [4 ]
Shi, Yuting [5 ]
Liu, Jun
Wei, Hongjiang [5 ]
Tong, Qiqi [6 ]
He, Hongjian [7 ]
Wu, Tao [1 ,2 ,3 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Ctr Movement Disorders, Beijing, Peoples R China
[2] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing, Peoples R China
[4] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Neurol & Inst Neurol, Sch Med, Shanghai, Peoples R China
[5] Shanghai Jiao Tong Univ, Inst Med Imaging Technol, Sch Biomed Engn, Shanghai, Peoples R China
[6] Zhejiang Lab, Res Ctr Healthcare Data Sci, Hangzhou, Zhejiang, Peoples R China
[7] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Ctr Brain Imaging Sci & Technol, Hangzhou, Zhejiang, Peoples R China
基金
国家重点研发计划; 美国国家卫生研究院; 中国国家自然科学基金;
关键词
leucine-rich repeat kinase 2; free water; biomarker; posterior substantia nigra; PARKINSONS-DISEASE; MULTISITE; ELIMINATION; BRAIN;
D O I
10.1002/mds.29253
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The alteration of substantia nigra (SN) degeneration in populations at risk of Parkinson's disease (PD) is unclear. Objective: We investigated free water (FW) values in the posterior SN (pSN) in asymptomatic LRRK2 G2019S mutation carriers. Methods: We analyzed diffusion imaging data from 28 asymptomatic LRRK2 G2019S mutation carriers and 30 healthy controls (HCs), whereas 11 asymptomatic LRRK2 G2019S carriers and 11 HCs were followed up. FW values in the pSN were measured and compared between the groups. The relationship between longitudinal changes in FW in the pSN and dopamine transporter striatal binding ratio (SBR) was analyzed. Results: FW values in the pSN were significantly elevated and kept increasing during follow-up in asymptomatic LRRK2 G2019S carriers. There was a negative correlation between FW changes in the left pSN and SBR changes in the left putamen. Conclusion: FW in the pSN has the potential to be a progression imaging marker of early dopaminergic degeneration in the population at risk of PD. (c) 2022 International Parkinson and Movement Disorder Society.
引用
收藏
页码:138 / 142
页数:5
相关论文
共 50 条
  • [31] Investigation of LRRK2 G2019S Mutation in the Patients with Sporadic Parkinson's Disease in Turkey
    Aslan, Huseyin
    Ozkan, Serhat
    Tepeli, Emre
    Emre, Ramazan
    Kutlay, Ozden
    Gurler, Abdullah Ihsan
    Uludag, Ahmet
    Muslumanoglu, M. Hamza
    KONURALP TIP DERGISI, 2014, 6 (01): : 1 - 4
  • [32] Frequency of the LRRK2 G2019S mutation in South African patients with Parkinson’s disease
    Nicola du Toit
    Riaan van Coller
    David G. Anderson
    Jonathan Carr
    Soraya Bardien
    neurogenetics, 2019, 20 : 215 - 218
  • [33] Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease
    Squillaro, Tiziana
    Cambi, Franca
    Ciacci, Giuseppe
    Rossi, Simone
    Ulivelli, Monica
    Malandrini, Alessandro
    Mencarelli, Maria Antonietta
    Mari, Francesca
    Renieri, Alessandra
    Ariani, Francesca
    JOURNAL OF HUMAN GENETICS, 2007, 52 (03) : 201 - 204
  • [34] The cellular and extracellular proteomic signature of human dopaminergic neurons carrying the LRRK2 G2019S mutation
    Knab, Felix
    Guaitoli, Giambattista
    Jarboui, Mohamed Ali
    von Zweydorf, Felix
    Isik, Fatma Busra
    Klose, Franziska
    Rajkumar, Anto Praveen
    Gasser, Thomas
    Gloeckner, Christian Johannes
    FRONTIERS IN NEUROSCIENCE, 2024, 18
  • [35] The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients
    Tan, EK
    Shen, H
    Tan, LCS
    Farrer, A
    Yew, K
    Chua, E
    Jamora, RD
    Puvan, K
    Puong, KY
    Zhao, Y
    Pavanni, R
    Wong, MC
    Yih, Y
    Skipper, L
    Liu, JJ
    NEUROSCIENCE LETTERS, 2005, 384 (03) : 327 - 329
  • [36] LRRK2 G2019S mutation does not contribute to Parkinson's disease in South India
    Vijayan, Bejoy
    Gopala, Srinivas
    Kishore, Asha
    NEUROLOGY INDIA, 2011, 59 (02) : 157 - 160
  • [37] Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease
    Marongiu, Roberta
    Ghezzi, Daniele
    Ialongo, Tamara
    Soleti, Francesco
    Elia, Antonio
    Cavone, Stefania
    Albanese, Alberto
    Altavista, Maria Concetta
    Barone, Paolo
    Brusa, Livia
    Cortelli, Pietro
    Petrozzi, Lucia
    Scaglione, Cesa
    Stanzione, Paolo
    Tinazzi, Michele
    Zeviani, Massimo
    Dallapiccola, Bruno
    Bentivoglio, Anna Rita
    Valente, Enza Maria
    Garavaglia, Barbara
    MOVEMENT DISORDERS, 2006, 21 (08) : 1232 - 1235
  • [38] LRRK2 gene G2019S mutation and SNPs [haplotypes] in subtypes of Parkinson's disease
    Patra, Biswanath
    Parsian, Azemat J.
    Racette, Brad A.
    Zhao, Jing Hua
    Perlmutter, Joel S.
    Parsian, Abbas
    PARKINSONISM & RELATED DISORDERS, 2009, 15 (03) : 175 - 180
  • [39] Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease
    Tiziana Squillaro
    Franca Cambi
    Giuseppe Ciacci
    Simone Rossi
    Monica Ulivelli
    Alessandro Malandrini
    Maria Antonietta Mencarelli
    Francesca Mari
    Alessandra Renieri
    Francesca Ariani
    Journal of Human Genetics, 2007, 52 : 201 - 204
  • [40] LRRK2 G2019S in the North African Population: A Review
    Benamer, Hani T. S.
    de Silva, Rajith
    EUROPEAN NEUROLOGY, 2010, 63 (06) : 321 - 325